Replies to post #176812 on NorthWest Biotherapeutics Inc (NWBO)

[monentum2play]

So do you think that LP called him in for DCVAX L to figure out to unblind. I agree with you that SAC are experts in their own field but not statisticians.

[Smokey21]

He is also the competition in a sense:

EF-14 Principal Investigator Roger Stupp, M.D., Associate Director for Strategic Initiatives at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, presented these late breaking results today, April 2, during a press briefing and oral presentation (Abstract CT007) at the American Association for Cancer Research Annual Meeting 2017 in Washington D.C.
“When I started treating patients with GBM 20 years ago, the majority of patients died within less than one year and long-term survival was nearly absent. Now, we see a meaningful improvement in survival at two years and beyond,” Dr. Stupp said. “With the combination of Optune and temozolomide, one out of seven patients is living longer than five years.”

He was probably there to understand the competitive environment for Optune.